The NLRP3 inflammasome pathway is activated in sarcoidosis and involved in granuloma formation

Christine Huppertz, Benedikt Jäger, Grazyna Wieczorek, Peggy Engelhard, Stephen J. Oliver, Franz-Georg Bauernfeind, Amanda Littlewood-Evans, Tobias Welte, Veit Hornung, Antje Prasse

Source: Eur Respir J, 55 (3) 1900119; 10.1183/13993003.00119-2019
Journal Issue: March
Disease area: Interstitial lung diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Christine Huppertz, Benedikt Jäger, Grazyna Wieczorek, Peggy Engelhard, Stephen J. Oliver, Franz-Georg Bauernfeind, Amanda Littlewood-Evans, Tobias Welte, Veit Hornung, Antje Prasse. The NLRP3 inflammasome pathway is activated in sarcoidosis and involved in granuloma formation. Eur Respir J, 55 (3) 1900119; 10.1183/13993003.00119-2019

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
In addition to mTOR and JAK/STAT, NLRP3 inflammasome is another key pathway activated in sarcoidosis
Source: Eur Respir J, 55 (3) 2000149; 10.1183/13993003.00149-2020
Year: 2020



The activation of NLRP3 inflammasome pathway in COPD is limited in local airways
Source: International Congress 2018 – Disease exacerbations from a molecular point of view
Year: 2018




Cigarette smoke extract inhibits the NLRP3 inflammasome in human macrophages and impairs cell metabolism via NLRP3-independent activation of Caspase-1
Source: International Congress 2019 – Effects of environmental exposures in lung pathology and the underlying mechanisms
Year: 2019

Andrographolide inhibits the activation of NLRP3 inflammasome in patients with COPD
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018



Statins worse pulmonary fibrosis through enhancing NLRP3 inflammasome activation
Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD
Year: 2012

Elevated expression of the NLRP3 inflammasome in neutrophilic asthma
Source: Eur Respir J 2014; 43: 1067-1076
Year: 2014



Late Breaking Abstract - 17-oxo-DHA inhibits the NLRP3 inflammasome downstream of mitochondrial ROS and ERK pathway
Source: International Congress 2017 – New Mechanistic Findings in COPD
Year: 2017

A role for the inflammasome effector caspase-1 in hypoxia-induced pulmonary hypertension
Source: International Congress 2017 – Experimental PH
Year: 2017


NLRP3 inflammasome conjugates with mitochondria in LPS-induced acute lung injury
Source: Virtual Congress 2020 – Cellular stress in respiratory diseases
Year: 2020


NLRP3 inflammasome is activated via phosphoinositide 3-kinase δ pathway in Aspergillus fumigatus-induced allergic airway inflammation
Source: International Congress 2015 – Animal studies of asthma and other inflammatory conditions
Year: 2015

Phagosome-regulated mTOR signalling during sarcoidosis granuloma biogenesis
Source: Eur Respir J, 57 (3) 2002695; 10.1183/13993003.02695-2020
Year: 2021



Activation of NLRP3 inflammasome is regulated by mitochondrial ROS via PI3K-HIF-VEGF pathway in acute lung injury
Source: International Congress 2015 – Novel insights into the pathobiology of acute lung injury
Year: 2015


Autophagy and the inflammasome
Source: Annual Congress 2013 –Inflammasomes in lung diseases
Year: 2013


Tetracycline alleviates acute lung injury by inhibition of NLRP3 inflammasome
Source: International Congress 2019 – ECMO, ECCO2R and other rescue therapies in acute respiratory failure
Year: 2019

Silica-induced inflammasome activation in lung epithelial cells
Source: Annual Congress 2012 - Abestosis, silicosis and hypersensitivity pneumonitis
Year: 2012

The NLRP3 inflammasome is not activated in airway smooth muscle upon TLR2 ligation
Source: Annual Congress 2013 –Airway smooth muscle and cell biology
Year: 2013

Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013

Role of NLRP3 inflammasome and ATP in S100A12-induced MUC5AC production in airway epithelial cells
Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases
Year: 2018




NLRP3 inflammasome expression in idiopathic pulmonary fibrosis and rheumatoid lung
Source: Eur Respir J 2016; 47: 910-918
Year: 2016



The role of inflammasomes in cystic fibrosis cells
Source: Annual Congress 2009 - Epithelial cell biology
Year: 2009